Seer

About:

Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.

Website: https://seer.bio/

Twitter/X: seer_bio

Top Investors: Fidelity, Invus, Wing Venture Capital, Emerson Collective, Maverick Ventures

Description:

Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.

Total Funding Amount:

$170M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)seer.bio

Founders:

Omid Farokhzad, Philip Ma

Number of Employees:

101-250

Last Funding Date:

2020-07-22

IPO Status:

Public

Industries:

© 2025 bioDAO.ai